Effects Of L-carnitine Supplementation On Lipid Profiles In Patients With Coronary Artery Disease
Notes for this study:
||At 12 weeks. Mean and SD. U/mg of protein Placebo: 13.1 ± 2.9 Carnitine: 20.7 ± 4.2
|Number of Subjects
In a randomized, single-blind, placebo-controlled trial, 47 CAD patients took 1 g of L-carnitine or placebo daily for 12 weeks. There was statistically significantly greater superoxide dismutase activity, HDL, and APO-A1 in the carnitine group, though it's unclear if this was due to differences at baseline. There weren't statistically significant differences for total cholesterol, triglycerides, LDL or Apo-B.